Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITOS |
---|---|---|
09:32 ET | 3019 | 16.06 |
09:34 ET | 584 | 16.01 |
09:36 ET | 100 | 15.975 |
09:38 ET | 1072 | 15.94 |
09:39 ET | 100 | 15.93 |
09:41 ET | 600 | 15.935 |
09:43 ET | 3691 | 15.9 |
09:45 ET | 2359 | 16.005 |
09:48 ET | 7289 | 16.08 |
09:50 ET | 600 | 16.1 |
09:52 ET | 200 | 16.1 |
09:54 ET | 2500 | 15.975 |
09:56 ET | 2329 | 16.1 |
09:57 ET | 2802 | 16.02 |
09:59 ET | 1736 | 15.98 |
10:01 ET | 3700 | 15.97 |
10:03 ET | 60653 | 15.91 |
10:06 ET | 600 | 15.915 |
10:08 ET | 1100 | 15.855 |
10:10 ET | 1700 | 15.855 |
10:12 ET | 2120 | 15.85 |
10:14 ET | 1541 | 15.89 |
10:15 ET | 200 | 15.895 |
10:17 ET | 1400 | 15.915 |
10:19 ET | 1200 | 15.84 |
10:21 ET | 867 | 15.875 |
10:24 ET | 100 | 15.875 |
10:26 ET | 1922 | 15.79 |
10:28 ET | 3670 | 15.8248 |
10:30 ET | 1000 | 15.81 |
10:32 ET | 8678 | 15.66 |
10:33 ET | 300 | 15.67 |
10:35 ET | 2417 | 15.67 |
10:37 ET | 900 | 15.67 |
10:39 ET | 300 | 15.67 |
10:42 ET | 1142 | 15.565 |
10:44 ET | 300 | 15.53 |
10:50 ET | 2007 | 15.51 |
10:51 ET | 3068 | 15.48 |
10:53 ET | 500 | 15.5 |
10:55 ET | 100 | 15.49 |
10:57 ET | 14068 | 15.52 |
11:00 ET | 100 | 15.47 |
11:02 ET | 1472 | 15.495 |
11:04 ET | 100 | 15.49 |
11:06 ET | 1935 | 15.44 |
11:08 ET | 1267 | 15.395 |
11:11 ET | 100 | 15.37 |
11:13 ET | 1200 | 15.385 |
11:15 ET | 800 | 15.385 |
11:18 ET | 2238 | 15.425 |
11:20 ET | 367 | 15.42 |
11:22 ET | 257 | 15.42 |
11:24 ET | 1465 | 15.44 |
11:26 ET | 100 | 15.43 |
11:27 ET | 600 | 15.43 |
11:29 ET | 802 | 15.43 |
11:31 ET | 100 | 15.45 |
11:33 ET | 14243 | 15.375 |
11:36 ET | 1369 | 15.315 |
11:38 ET | 1602 | 15.37 |
11:40 ET | 100 | 15.38 |
11:44 ET | 932 | 15.35 |
11:45 ET | 100 | 15.36 |
11:47 ET | 2284 | 15.26 |
11:49 ET | 590 | 15.25 |
11:51 ET | 3232 | 15.245 |
11:54 ET | 1554 | 15.21 |
11:56 ET | 21199 | 15.24 |
11:58 ET | 8013 | 15.4299 |
12:00 ET | 48439 | 16.13 |
12:02 ET | 7848 | 15.79 |
12:03 ET | 3595 | 15.71 |
12:05 ET | 6055 | 15.645 |
12:09 ET | 1280 | 15.55 |
12:12 ET | 300 | 15.55 |
12:14 ET | 3045 | 15.63 |
12:16 ET | 2111 | 15.67 |
12:18 ET | 690 | 15.67 |
12:20 ET | 500 | 15.65 |
12:21 ET | 300 | 15.69 |
12:23 ET | 500 | 15.68 |
12:25 ET | 3043 | 15.745 |
12:27 ET | 1200 | 15.81 |
12:30 ET | 496 | 15.82 |
12:32 ET | 900 | 15.68 |
12:34 ET | 423 | 15.67 |
12:36 ET | 200 | 15.68 |
12:38 ET | 822 | 15.53 |
12:39 ET | 300 | 15.52 |
12:41 ET | 300 | 15.58 |
12:43 ET | 700 | 15.565 |
12:45 ET | 600 | 15.52 |
12:48 ET | 200 | 15.54 |
12:50 ET | 1139 | 15.52 |
12:52 ET | 300 | 15.57 |
12:54 ET | 800 | 15.58 |
12:56 ET | 800 | 15.56 |
12:57 ET | 100 | 15.53 |
01:03 ET | 338 | 15.59 |
01:06 ET | 865 | 15.62 |
01:08 ET | 200 | 15.62 |
01:12 ET | 3099 | 15.63 |
01:15 ET | 1300 | 15.59 |
01:17 ET | 227 | 15.62 |
01:19 ET | 100 | 15.6 |
01:21 ET | 371 | 15.63 |
01:24 ET | 856 | 15.6 |
01:26 ET | 600 | 15.525 |
01:28 ET | 1604 | 15.52 |
01:30 ET | 400 | 15.5 |
01:32 ET | 327 | 15.54 |
01:33 ET | 100 | 15.515 |
01:35 ET | 399 | 15.515 |
01:37 ET | 227 | 15.54 |
01:39 ET | 100 | 15.515 |
01:42 ET | 200 | 15.48 |
01:44 ET | 157 | 15.54 |
01:46 ET | 2874 | 15.48 |
01:48 ET | 206 | 15.48 |
01:50 ET | 100 | 15.53 |
01:51 ET | 3440 | 15.515 |
01:53 ET | 100 | 15.54 |
01:55 ET | 2131 | 15.6 |
01:57 ET | 100 | 15.61 |
02:00 ET | 500 | 15.575 |
02:02 ET | 1036 | 15.61 |
02:06 ET | 2302 | 15.62 |
02:09 ET | 300 | 15.66 |
02:11 ET | 1000 | 15.645 |
02:13 ET | 1600 | 15.68 |
02:15 ET | 400 | 15.65 |
02:20 ET | 200 | 15.645 |
02:22 ET | 1100 | 15.62 |
02:24 ET | 700 | 15.565 |
02:26 ET | 200 | 15.54 |
02:27 ET | 1474 | 15.565 |
02:29 ET | 300 | 15.57 |
02:31 ET | 1300 | 15.54 |
02:33 ET | 34956 | 15.375 |
02:36 ET | 600 | 15.385 |
02:38 ET | 1127 | 15.335 |
02:40 ET | 200 | 15.27 |
02:42 ET | 6581 | 15.265 |
02:44 ET | 100 | 15.24 |
02:45 ET | 1644 | 15.19 |
02:47 ET | 1577 | 15.22 |
02:49 ET | 12352 | 15.34 |
02:51 ET | 200 | 15.34 |
02:54 ET | 800 | 15.3186 |
02:56 ET | 4072 | 15.28 |
02:58 ET | 375 | 15.27 |
03:00 ET | 1637 | 15.275 |
03:02 ET | 1400 | 15.28 |
03:03 ET | 400 | 15.2 |
03:05 ET | 300 | 15.17 |
03:07 ET | 1700 | 15.21 |
03:09 ET | 3350 | 15.17 |
03:12 ET | 1300 | 15.2 |
03:14 ET | 1000 | 15.2 |
03:16 ET | 8208 | 15.33 |
03:18 ET | 1022 | 15.31 |
03:20 ET | 330 | 15.31 |
03:21 ET | 2532 | 15.36 |
03:23 ET | 1430 | 15.45 |
03:25 ET | 318 | 15.4364 |
03:27 ET | 1848 | 15.38 |
03:32 ET | 1418 | 15.35 |
03:34 ET | 1805 | 15.35 |
03:36 ET | 1437 | 15.345 |
03:39 ET | 5055 | 15.28 |
03:43 ET | 700 | 15.24 |
03:45 ET | 2440 | 15.249 |
03:48 ET | 7104 | 15.26 |
03:50 ET | 1674 | 15.23 |
03:52 ET | 3307 | 15.265 |
03:54 ET | 2323 | 15.335 |
03:56 ET | 5095 | 15.3 |
03:57 ET | 11661 | 15.27 |
03:59 ET | 6302 | 15.25 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Iteos Therapeutics Inc | 586.3M | -4.0x | --- |
Applied Therapeutics Inc | 577.1M | -2.5x | --- |
Arbutus Biopharma Corp | 592.6M | -7.0x | --- |
Annexon Inc | 581.6M | -3.7x | --- |
AnaptysBio Inc | 649.4M | -3.8x | --- |
Larimar Therapeutics Inc | 599.1M | -8.3x | --- |
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $586.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-3.78 |
Book Value | $16.05 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.